FYR Bio Appoints Barbara K. Zehentner, MBA, PhD, HCLD (ABB), as COO
Veteran laboratory operations leader brings deep expertise scaling high-complexity CLIA/CAP environments and multiomic platforms to support FYR’s EV-Omics growth across neuroscience and oncology FYR Bio (“FYR”), a biotechnology company leveraging extracellular vesicles (EVs) to deliver AI-enabled multiomic insights from a peripheral blood sample, today announced the appointment of Barbara K. Zehentner, MBA, PhD, HCLD (ABB), as…
